.jpg)
Merck ‘willing to work’ with Trump administration on price gap between US, international medicines
The company's CEO, Rob Davis, is joining his industry peers in pushing for greater rewards for innovation in countries outside of the U.S., where drug prices are often substantially lower.
The company's CEO, Rob Davis, is joining his industry peers in pushing for greater rewards for innovation in countries outside of the U.S., where drug prices are often substantially lower.
